期刊
JOURNAL OF PHYSICAL CHEMISTRY LETTERS
卷 13, 期 35, 页码 8359-8364出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jpclett.2c01998
关键词
-
类别
资金
- National Science Foundation [CBET-2011317]
The S2 subunit of the SARS-CoV-2 S protein inhibits the biophysical properties of pulmonary surfactant and induces microdomain fusion in the surfactant monolayer. These findings provide important insights into the mechanisms of surfactant-virus interactions and the development of surfactant replacement therapy for COVID-19.
Pulmonary surfactant has been attempted as a supportive therapy to treat COVID19. Although it is mechanistically accepted that the fusion peptide in the S2 subunit of the S protein plays a predominant role in mediating viral fusion with the host cell membrane, it is still unknown how the S2 subunit interacts with the natural surfactant film. Using combined biophysicochemical assays and atomic force microscopy imaging, it was found that the S2 subunit inhibited the biophysical properties of the surfactant and induced microdomain fusion in the surfactant monolayer. The surfactant inhibition has been attributed to membrane fluidization caused by insertion of the S2 subunit mediated by its fusion peptide. These findings may provide novel insight into the understanding of bio-physicochemical mechanisms responsible for surfactant interactions with SARS-CoV-2 and may have translational implications in the further development of surfactant replacement therapy for COVID-19 patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据